Bioclinica said yesterday it picked up clinical trial financial management tech firm Clinverse for an undisclosed amount. Clinverse, based in Durham, N.C., manages and automates financial aspects of global clinical trials for contract research organizations and pharmaceutical companies, Bioclinica said. “We are delighted to add Clinverse’s capabilities to Bioclinica’s portfolio of solutions. Managing clinical investigator […]
BioClinica Inc.
BioClinica launches eHealth Cloud service
BioClinica said today it launched its eHealth Cloud service platform designed to improve pre-approval and post-approval clinical trial research. The platform service provides public consumer, private cloud, managed cloud and custom options for researchers involved in clinical trials, the Newton, Pa.-based company said. “The eHealth Cloud is an exciting new delivery model for BioClinica’s eClinical […]
Ballantyne takes CFO post at Avedro | Personnel Moves
Waltham, Mass.-based medical device and pharmaceutical company Avedro appointed industry veteran C. Evan Ballantyne as its new chief financial officer.
Prior to the appointment, Ballantyne was the VP & CFO of biopharmaceutical company Clinical Data Inc., chief financial officer of Beverly, Mass.-based ZymeQuest, and vice president at chief operating officer at the ACNielsen Corporation.
BioClinica appoints Andrzej Dzik-Jurasz as its new medical director
BioClinica Appoints Senior Medical Director, Dr. Andrzej Dzik-Jurasz
New Position Expands Scientific Coverage for MRI Imaging and Oncology
NEWTOWN, Pa.–(BUSINESS WIRE)–BioClinica®, Inc. (NASDAQ: BIOC), a global provider of clinical trial management solutions, today announced the appointment of Andrzej (Andy) Dzik-Jurasz, M.D., Ph.D. as Senior Medical Director for Medical Affairs, a newly created position. Dr. Dzik-Jurasz brings more than 15 years of clinical, radiological and pharmaceutical industry experience with major pharmaceutical companies such as Novartis Pharmaceuticals and GlaxoSmithKline.
Allergan profits slimmer despite plumper sales | Earnings roundup
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Alere’s losses break the billion mark | Earnings roundup
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
BioClinica posts Q4 profit, sales increase
BioClinica Inc. (NSDQ:BIOC) posted fourth-quarter sales of $20.2 million for the three months ended Dec. 31, 2009, up 14.3 percent compared with $17.7 million during the same period in 2008. Net income reached $943,000, compared with a net loss of $171,000 during Q4 2008:
